Evidence map›Paper›PMID 36207737›Full record

ArticleCritical care (London, England)2022

Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors.

Alice Blet, Joel B McNeil, Julie Josse, Bernard Cholley, Raphaël Cinotti, Gad Cotter, Agnès Dauvergne, Beth Davison, Kévin Duarte, Jacques Duranteau and 13 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01367093 (French and EuRopean Outcome Registry in Intensive Care Unit), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01367093 completednot on this map

French and EuRopean Outcome Registry in Intensive Care Unit

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2011 to 2015Enrolled2,137ConditionsIntensive Care Unit Syndrome, Tracheal Intubation Morbidity
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Cost Reduction in Blood Transfusions After Implementation of Decision Protocol Based on Hemoglobin and Anemia Symptoms: A Pre-Post Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  14. Article
  15. Observational
  16. Article
  17. Response to "Not All Grams per Deciliter of Hemoglobin Are Equal".Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 17 institutions in 5 countries.

Alice Blet *Université Paris Cité, Department of Anesthesiology, Critical Care and Burn Unit, INSERM, UMR-S 942, MASCOT, FCRIN INI-CRCT, Hôpitaux Universitaires Saint Louis - Lariboisière, Assistance Publique - Hôpitaux de Paris, Paris, France.
Joel B McNeil *Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, University School of Medicine, Nashville, Vanderbilt, TN, USA.
Julie Josse *Université de Montpellier, IDESP-Institut Desbrest d'Épidémiologie et de Santé Publique, PREMEDICAL - Médecine de Précision Par Intégration de Données et Inférence Causale, CRISAM- Inria Sophia Antipolis - Méditerranée, Montpellier, France.
Bernard CholleyUniversité Paris Cité, INSERM UMR_S 1140 "Innovations Thérapeutiques en Hémostase", 75006, Paris, France.
Raphaël CinottiUniversity of Nantes, Department of Anesthesia and Critical Care, Hôtel Dieu, Intensive Care Unit, University Hospital of Nantes, Nantes, France.
Gad CotterMomentum Research, Inc., Chapel Hill, NC, 27517, USA.
Agnès DauvergneUniversité Paris Cité, Department of Biochemistry, Assistance Publique - Hôpitaux de Paris, Hôpital Beaujon, Clichy, France.
Beth DavisonMomentum Research, Inc., Chapel Hill, NC, 27517, USA.
Kévin DuarteUniversité de Lorraine, INSERM 1433 CIC-P CHRU de Nancy, Inserm U1116 and FCRIN INI-CRCT, Nancy, France.
Jacques DuranteauUniversité Paris-Sud, Anesthesia and Intensive Care Department, Assistance Publique Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
Marie-Céline FournierUniversité Paris Cité, Department of Anesthesiology, Critical Care and Burn Unit, INSERM, UMR-S 942, MASCOT, FCRIN INI-CRCT, Hôpitaux Universitaires Saint Louis - Lariboisière, Assistance Publique - Hôpitaux de Paris, Paris, France.
Etienne GayatUniversité Paris Cité, Department of Anesthesiology, Critical Care and Burn Unit, INSERM, UMR-S 942, MASCOT, FCRIN INI-CRCT, Hôpitaux Universitaires Saint Louis - Lariboisière, Assistance Publique - Hôpitaux de Paris, Paris, France.
Samir JaberUniversité de Montpellier, Department of Anesthesia and Intensive Care Unit, PhyMedExp, INSERM U1046, CNRS UMR, 9214, CHRU de Montpellier, Hôpital Saint Eloi, Montpellier, France.
Sigismond LasockiUniversité d'Angers, Department of Anesthesia and Intensive Care Unit, CHU d'Angers, Angers, France.
Thomas MerklingUniversité de Lorraine, INSERM 1433 CIC-P CHRU de Nancy, Inserm U1116 and FCRIN INI-CRCT, Nancy, France.
Katell Peoc'hUniversité Paris Cité, Department of Biochemistry, CRI INSERM UMR1149, HUPNVS, Assistance Publique - Hôpitaux de Paris, Paris, France.
Imke MayerInstitute for Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Malha SadouneUniversité Paris Cité, Department of Anesthesiology, Critical Care and Burn Unit, INSERM, UMR-S 942, MASCOT, FCRIN INI-CRCT, Hôpitaux Universitaires Saint Louis - Lariboisière, Assistance Publique - Hôpitaux de Paris, Paris, France.
Pierre-François LaterreIntensive Care Unit, Clinique Universitaire St Luc UCL, Brussels, Belgium.
Romain SonnevilleUniversité Paris Cité, Department of Intensive Care Medicine, INSERM UMR1148, HUPNVS, Assistance Publique - Hôpitaux de Paris, Paris, France.
Lorraine Ware *Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, University School of Medicine, Nashville, Vanderbilt, TN, USA.
Alexandre Mebazaa *Université Paris Cité, Department of Anesthesiology, Critical Care and Burn Unit, INSERM, UMR-S 942, MASCOT, FCRIN INI-CRCT, Hôpitaux Universitaires Saint Louis - Lariboisière, Assistance Publique - Hôpitaux de Paris, Paris, France. alexandre.mebazaa@aphp.fr.
Antoine Kimmoun *Université de Lorraine, CHRU de Nancy, Intensive Care Medicine Babois, INSERM U1116, FCRIN INI-CRCT, Nancy, France.
French Clinical Research Infrastructure Network · FRHôpital Fernand-Widal · FRInserm · FRMomentum Research · USVanderbilt University · USAssistance Publique – Hôpitaux de Paris · FRBicêtre Hospital · FRCentre d'Investigation Clinique de Nantes · FRCentre d'Investigation Clinique Pierre Drouin · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire d'Angers · FRCentre National de la Recherche Scientifique · FRCharité - Universitätsmedizin Berlin · DECliniques Universitaires Saint-Luc · BEInstitut Universitaire de Recherche Clinique · FRSorbonne Paris Cité · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImpact of in-ICU transfusion on long-term outcomes remains unknown. The purpose of this study was to assess in critical-care survivors the association between in-ICU red blood cells transfusion and 1-year mortality.

methodsFROG-ICU, a multicenter European study enrolling all-comers critical care patients was analyzed (n = 1551). Association between red blood cells transfusion administered in intensive care unit and 1-year mortality in critical care survivors was analyzed using an augmented inverse probability of treatment weighting-augmented inverse probability of censoring weighting method to control confounders.

resultsAmong the 1551 ICU-survivors, 42% received at least one unit of red blood cells while in intensive care unit. Patients in the transfusion group had greater severity scores than those in the no-transfusion group. According to unweighted analysis, 1-year post-critical care mortality was greater in the transfusion group compared to the no-transfusion group (hazard ratio (HR) 1.78, 95% CI 1.45-2.16). Weighted analyses including 40 confounders, showed that transfusion remained associated with a higher risk of long-term mortality (HR 1.21, 95% CI 1.06-1.46).

conclusionsOur results suggest a high incidence of in-ICU RBC transfusion and that in-ICU transfusion is associated with a higher 1-year mortality among in-ICU survivors. Trial registration ( NCT01367093 ; Registered 6 June 2011).

Indexed as

Erythrocyte TransfusionIntensive Care UnitsErythrocytesHumansProspective StudiesSurvivorsCritical care unitMortalityTransfusion

Identifiers

PMID36207737
PMCPMC9547456
OpenAlexW4303427285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.